Pressure Ulcers Market Projected to Reach $5.6 Billion by 2031

Portland, Oregon – The global market for pressure ulcer treatments reached $3.7 billion in 2021, according to Allied Market Research. The market is projected to grow to $5.6 billion by 2031, at a compound annual growth rate (CAGR) of 4.2% from 2022 to 2031.

Pressure ulcers, also known as bedsores or decubitus ulcers, are injuries to the skin and tissue resulting from prolonged pressure or pressure combined with friction. They commonly occur on areas like the sacrum, heels, hips, and coccyx, but can also affect knees, elbows, ankles, and the back of the cranium. The market encompasses the sale of medications and other treatments used for pressure ulcers.

Several factors are driving market growth, including an increasing prevalence of pressure ulcers, a rise in the geriatric population who are more susceptible to developing these injuries, and growing awareness of available treatments. The demand for wound care dressings also contributes to market expansion. For instance, approximately 2.5 million people in the U.S. were affected by pressure ulcers in 2020, and around 71% of these ulcers develop in patients over 70 years old.

However, market growth is constrained by the high cost of treatments and potential side effects of drug therapies, such as gastrointestinal upset and blood pressure changes. Despite these challenges, analysts anticipate that the increasing demand for pressure ulcer treatments will create new market opportunities.

The market is segmented by type (Stage 1, Stage 2, Stage 3, Stage 4, and Deep Tissue Injury), treatment type (Wound Care Dressing, Wound Care Devices, and Others), and end-user (Hospitals, Homecare, and Others). In 2021, Stage 1 ulcers represented the largest segment, though Stage 2 ulcers are expected to register the fastest CAGR during the forecast period.